Overview

Comparison Between Technosphere/Insulin Inhalation Powder Versus Rapid Acting Insulin in Subjects With Type 2 Diabetes Mellitus

Status:
Completed

Trial end date:
2006-07-01

Target enrollment:

Participant gender:

Summary

To compare the efficacy of prandial TI plus basal insulin versus prandial rapid acting, subcutaneous insulin plus basal insulin in subjects with type 2 diabetes who had an HbA1c >7.0% and <11.5%.

Phase:

Phase 3

Details

Lead Sponsor:

Mannkind Corporation

Treatments:

Insulin
Insulin, Globin Zinc
Insulin, Short-Acting